Clonidine compounds in a biodegradable polymer

USRE48948E1 · kind E1 · reissue

Assignee

• Warsaw Orthopedic, Inc.

Inventors

• Danielle L. Clay · Collierville, US
• Josee Roy · Memphis, US
• William F. McKay · Memphis, US

Key dates

• Filing date: Apr 3, 2019
• Grant date: Mar 1, 2022
• Expiry date: Apr 3, 2039

Classification

• Technology area (CPC —): General

Abstract

Effective treatments of pain for extended periods of time are provided. Through the administration of an effective amount of clonidine in a drug depot at or near a target site, one can relieve pain caused by diverse sources, including but not limited to spinal disc herniation (i.e. sciatica), spondilothesis, stenosis, discogenic back pain and joint pain. When appropriate drug depot formulations are provided within biodegradable polymers, this pain relief can be continued for at least fourteen days.